Search results
Found 18183 matches for
Results from an insight review commissioned by the Wellcome Trust, highlights what is currently known about the benefits and risks of using selective serotonin reuptake inhibitors (SSRIs) for the treatment of depression and anxiety in young people.
Kirsten Rowe
MB ChB (Stell), DPhil (Oxon) Kirsten Rowe - Registrar in Psychiatry
Vanessa Raymont
MBChB MSc MRCPsych Vanessa Raymont - Associate Professor, R&D Director Oxford Health NHS Foundation Trust
Maike van Niekerk
BScN Maike van Niekerk - DPhil in Psychiatry Student
Willem Kuyken
PhD, DClinPsy Willem Kuyken - Ritblat Professor of Mindfulness and Psychological Science
Matthew Gee
BSc(Hons) MB ChB DCP MRCGP MRCPsych Matthew Gee - Honorary Teaching Fellow
Jessica Lorimer
Jessica Lorimer - DPhil Student and Postdoctoral Researcher
John Gallacher
PhD AFBPsS CPsychol FFPH John Gallacher - Professor of Cognitive Health; Director, Dementias Platform UK; Director, BrainWaves study of adolescent wellbeing and mental health
Symon Kariuki
BScN (UoN), MSc (London), DPhil (Oxford) Symon Kariuki - Postdoctoral Research Scientist
Keith Hawton CBE
DSc., DM, FRCPsych, FMedSci. Keith Hawton CBE - Emeritus Director, Centre for Suicide Research
Beata Godlewska
Beata Godlewska - Clinical Researcher, Honorary Consultant Psychiatrist
Philip Wilkinson
BMedSci BM BS (Nottingham), FRCPsych, Dip Obst (Auckland, New Zealand), Certificate in Cognitive Therapy (Oxford), ATCL, LGSMD, CELTA Philip Wilkinson - Honorary Senior Clinical Lecturer